Founder's Consultants Holdings Inc
TSE:6542
Founder's Consultants Holdings Inc
TSE:6542
Price:
805
JPY
-0.25%
Market Closed
Market Cap:
¥8.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Founder's Consultants Holdings Inc
TSE:6542
|
JP |
|
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
|
PR |
Cash Flow Statement
Cash Flow Statement
Founder's Consultants Holdings Inc
Founder's Consultants Holdings Inc
Currency: JPY
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Net Income |
744
|
737
|
729
|
835
|
448
|
673
|
1 550
|
1 238
|
1 333
|
1 210
|
1 173
|
1 163
|
1 268
|
1 137
|
|
| Depreciation & Amortization |
137
|
136
|
140
|
163
|
200
|
201
|
185
|
184
|
196
|
203
|
195
|
188
|
155
|
159
|
|
| Other Non-Cash Items |
13
|
1
|
2
|
9
|
310
|
282
|
(10)
|
11
|
69
|
(5)
|
(66)
|
(31)
|
70
|
7
|
|
| Cash Taxes Paid |
238
|
253
|
380
|
366
|
283
|
296
|
365
|
463
|
420
|
404
|
376
|
253
|
339
|
495
|
|
| Cash Interest Paid |
3
|
3
|
4
|
12
|
19
|
17
|
15
|
13
|
11
|
10
|
9
|
9
|
9
|
11
|
|
| Change in Working Capital |
(382)
|
(441)
|
(579)
|
(986)
|
(89)
|
335
|
(847)
|
(784)
|
(980)
|
(789)
|
(845)
|
(602)
|
(793)
|
(523)
|
|
| Cash from Operating Activities |
511
N/A
|
434
-15%
|
292
-33%
|
22
-93%
|
869
+3 930%
|
1 491
+72%
|
877
-41%
|
648
-26%
|
618
-5%
|
620
+0%
|
456
-26%
|
718
+57%
|
716
0%
|
780
+9%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(247)
|
(226)
|
(614)
|
(1 903)
|
(1 770)
|
(358)
|
(133)
|
(174)
|
(184)
|
(165)
|
(200)
|
(284)
|
(291)
|
(174)
|
|
| Other Items |
(39)
|
(19)
|
(20)
|
(505)
|
(484)
|
24
|
127
|
31
|
(39)
|
4
|
58
|
321
|
231
|
(30)
|
|
| Cash from Investing Activities |
(286)
N/A
|
(245)
+14%
|
(633)
-159%
|
(2 407)
-280%
|
(2 255)
+6%
|
(334)
+85%
|
(6)
+98%
|
(144)
-2 266%
|
(223)
-55%
|
(162)
+27%
|
(142)
+12%
|
37
N/A
|
(60)
N/A
|
(204)
-241%
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Common Stock |
22
|
23
|
23
|
23
|
23
|
22
|
5
|
(1)
|
(1)
|
(2)
|
(0)
|
8
|
49
|
51
|
|
| Net Issuance of Debt |
(30)
|
(30)
|
620
|
2 227
|
1 705
|
(751)
|
(614)
|
(655)
|
(351)
|
(652)
|
(93)
|
(514)
|
(608)
|
(41)
|
|
| Cash Paid for Dividends |
(94)
|
(94)
|
(104)
|
(104)
|
(107)
|
(107)
|
(94)
|
(94)
|
(130)
|
(131)
|
(156)
|
(155)
|
(198)
|
(198)
|
|
| Other |
0
|
0
|
(0)
|
(0)
|
(9)
|
(9)
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Cash from Financing Activities |
(101)
N/A
|
(101)
0%
|
539
N/A
|
2 146
+298%
|
1 612
-25%
|
(845)
N/A
|
(702)
+17%
|
(750)
-7%
|
(482)
+36%
|
(785)
-63%
|
(250)
+68%
|
(661)
-164%
|
(757)
-14%
|
(189)
+75%
|
|
| Change in Cash | |||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Net Change in Cash |
124
N/A
|
89
-29%
|
198
+123%
|
(240)
N/A
|
227
N/A
|
313
+38%
|
169
-46%
|
(245)
N/A
|
(87)
+64%
|
(327)
-276%
|
64
N/A
|
93
+45%
|
(101)
N/A
|
388
N/A
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
265
N/A
|
209
-21%
|
(322)
N/A
|
(1 881)
-485%
|
(901)
+52%
|
1 133
N/A
|
744
-34%
|
474
-36%
|
434
-8%
|
454
+5%
|
256
-44%
|
433
+69%
|
425
-2%
|
607
+43%
|
|
Switch to:
Switch to:
See Also
Discover More
